Search results
Results from the WOW.Com Content Network
The New England Journal of Medicine (NEJM) is a weekly medical journal published by the Massachusetts Medical Society. Founded in 1812, the journal is among the most prestigious peer-reviewed medical journals. [1] Its 2023 impact factor was 96.2, ranking it 2nd out of 168 journals in the category "Medicine, General & Internal". [2]
The organization accomplishes this by utilizing a board of physicians and editors who monitor scientific and medical journals for relevant articles, summarize the articles, and provide additional commentary about the topic. NEJM Journal Watch divides its content into areas of primary care, specialty care, and specific watch topics.
The Massachusetts Medical Society owns and publishes The New England Journal of Medicine, the most widely read and cited medical journal in the world.The New England Journal of Medicine is also the oldest continuously published and circulating medical journal in the world and has an impact factor of 91.2, the highest among all the medical journals in the world.
This is a list of open-access journals by field. The list contains notable journals which have a policy of full open access. It does not include delayed open access journals, hybrid open access journals, or related collections or indexing services.
The New England Journal of Medicine: Medicine: Massachusetts Medical Society: English: 1812–present The New Zealand Medical Journal: Medicine: New Zealand Medical Association: English: 1887–present Nippon Naibunpi Gakkai Zasshi: Endocrinology: Japan Endocrine Society: Japanese: 1925–present Nursing Children and Young People: Pediatrics ...
Angell joined the editorial staff of The New England Journal of Medicine (NEJM) in 1979. She became Executive Editor in 1988, and served as interim Editor-in-Chief from 1999 until June 2000. [ 3 ] The NEJM is the oldest continuously published medical journal, [ 4 ] and one of the most prestigious; Angell is the first woman to have served as ...
An article in the May issue of the New England Journal of Medicine called for wider U.S. use of medication-assisted therapies for addicts, commonly referred to as MATs. It was written by Dr. Nora Volkow, director of the U.S. National Institute on Drug Abuse — which helped research Suboxone before it earned FDA approval in 2002 — along with ...
The Ingelfinger rule is an eponymous rule named after Franz J. Ingelfinger, The New England Journal of Medicine (NEJM) editor-in-chief who enunciated it in 1969.Editorials in most journals were published anonymously that time, so the paper was published without an author's name. [1]